In patients with type 1 diabetes (T1D),weekly insulins could benefit, not only with the reduction in injection number, butpotentially from a reduction in the frequency of recurrent diabetes ketoacidosis in those athighest risk, for example, adolescents whose compliance with insulin therapy can beinconsistent. The gene discussed is INS; the disease is diabetic ketoacidosis.